Product
Supplier
Encyclopedia
Inquiry
Home > Encyclopedia > Alfacalcidol

Alfacalcidol

pharmaceutical raw materials
Alfacalcidol structure

Alfacalcidol 

structure
  • CAS No:

    41294-56-8

  • Formula:

    C27H44O2

  • Chemical Name:

    Alfacalcidol

  • Synonyms:

    1,3-Cyclohexanediol,5-[(2E)-2-[(1R,3aS,7aR)-1-[(1R)-1,5-dimethylhexyl]octahydro-7a-methyl-4H-inden-4-ylidene]ethylidene]-4-methylene-,(1R,3R)-;9,10-Secocholesta-5,7,10(19)-triene-1,3-diol,(1α,3β,5Z,7E)-;(1R,3R)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(1R)-1,5-Dimethylhexyl]octahydro-7a-methyl-4H-inden-4-ylidene]ethylidene]-4-methylene-1,3-cyclohexanediol;1α-Hydroxycholecalciferol;1α-Hydroxyvitamin D3;1-Hydroxycholecalciferol;1-Hydroxyvitamin D3;Alfacalcidol;Un Alpha;α-Calcidol;Alfarol;Alphacalcidol;Oxydevit;Alpharol;Bondiol;Un Alfa;Etalpha;1α(OH)D3;Alpha D3;EinsAlpha;(1S)-Hydroxycalciol;Tevabone;125324-15-4;41461-06-7;43157-29-5;43217-90-9

  • Categories:

    Active Pharmaceutical Ingredients  >  Vitamins and Minerals Medicines

Description

Alfacalcidol (1-hydroxycholecalciferol; Alpha D3; 1.alpha.-Hydroxyvitamin D3) is a non-selective VDR activator medication. IC50 value: Target: VDR activatorAlfacalcidol (1-hydroxycholecalciferol; Alpha D3; 1.alpha.-Hydroxyvitamin D3) improves mechanical bone strength and bone mass; suppresses osteoclastic bone resorption in vivo.

Alfacalcidol Basic Attributes

400.64

400.64

255-297-1

DTXSID0022569

A - Alimentary tract and metabolism

29361000

Characteristics

40.46000

8.31

Solid

1.0±0.1 g/cm3

136 °C

531.5±50.0 °C at 760 mmHg

222.6±24.7 °C

1.534

1.63e-03 g/L

−20°C

Safety Information

I

6.1(a)

UN 2811 6.1/PG 1

3

26/27/28-36/37/38

28-36/37-45-36-26

VS2851000

T+,Xi

Missing Phrase - N15.00950417-P260-P262-P280-P302 + P352 + P310-P304 + P340 + P310

H300 + H310 + H330

|Danger|H300 (100%): Fatal if swallowed [Danger Acute toxicity, oral]|P260, P262, P264, P270, P271, P280, P284, P301+P310, P302+P350, P304+P340, P310, P320, P321, P322, P330, P361, P363, P403+P233, P405, and P501|Aggregated GHS information provided by 47 companies from 6 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Drug Information

Agents that inhibit BONE RESORPTION and/or favor BONE MINERALIZATION and BONE REGENERATION. They are used to heal BONE FRACTURES and to treat METABOLIC BONE DISEASES such as OSTEOPOROSIS. (See all compounds classified as Bone Density Conservation Agents.)

1 alpha-hydroxycholecalciferol

Alfacalcidol Use and Manufacturing

A synthetic analog of Calcitiol (the hormonal form of vitamin D3), which shows identical potency with respect to stimulation of intestinal calcium absorption and bone mineral mobilization. Vitamin D source

Computed Properties

Molecular Weight:400.6
XLogP3:6.8
Hydrogen Bond Donor Count:2
Hydrogen Bond Acceptor Count:2
Rotatable Bond Count:6
Exact Mass:400.334130642
Monoisotopic Mass:400.334130642
Topological Polar Surface Area:40.5
Heavy Atom Count:29
Complexity:643
Undefined Atom Stereocenter Count:6
Undefined Bond Stereocenter Count:2
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes

Drug Function and Efficacy

Extract from the above information

This ingredient has been used in drugs with the following functions (note: it does not mean that the ingredient itself has the following health functions)

Related Drugs

Registered Holders

  • FORMOSA LABORATORIES, INC.

    China China
    Active
  • Beijing Ansenbo Pharmaceutical Technology Co., Ltd.

    China China
    Active
  • Qingdao Guoxin Pharmaceutical Co., Ltd.

    China China
    Active

Recommended Suppliers of Alfacalcidol

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.